• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA sets April date for verdict on Incyte’s vitiligo drug

cafead

Administrator
Staff member
  • cafead   Dec 15, 2021 at 11:12: AM
via Incyte could be a few month away from a second FDA approval for its Opzelura cream that would make it the first medical treatment to re-pigment the skin of people with vitiligo.

article source
 

<